<SEC-DOCUMENT>0001144204-16-104923.txt : 20160525
<SEC-HEADER>0001144204-16-104923.hdr.sgml : 20160525
<ACCEPTANCE-DATETIME>20160525203052
ACCESSION NUMBER:		0001144204-16-104923
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20160523
FILED AS OF DATE:		20160525
DATE AS OF CHANGE:		20160525

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ReWalk Robotics Ltd.
		CENTRAL INDEX KEY:			0001607962
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				000000000

	BUSINESS ADDRESS:	
		STREET 1:		KOCHAV YOKNEAM BUILDING, FLOOR 6
		STREET 2:		P.O. BOX 161
		CITY:			YOKNEAM ILIT
		STATE:			L3
		ZIP:			20692
		BUSINESS PHONE:		97249590123

	MAIL ADDRESS:	
		STREET 1:		KOCHAV YOKNEAM BUILDING, FLOOR 6
		STREET 2:		P.O. BOX 161
		CITY:			YOKNEAM ILIT
		STATE:			L3
		ZIP:			20692

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Argo Medical Technologies Ltd.
		DATE OF NAME CHANGE:	20140513

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Dykan Jeff
		CENTRAL INDEX KEY:			0001661229

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36612
		FILM NUMBER:		161676037

	MAIL ADDRESS:	
		STREET 1:		KOCHAV YOKNEAM BUILDING, FLOOR 6
		STREET 2:		P.O. BOX 161
		CITY:			YOKNEAM ILIT
		STATE:			L3
		ZIP:			20692
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>v441031_4.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2016-05-23</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001607962</issuerCik>
        <issuerName>ReWalk Robotics Ltd.</issuerName>
        <issuerTradingSymbol>RWLK</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001661229</rptOwnerCik>
            <rptOwnerName>Dykan Jeff</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O REWALK ROBOTICS, LTD.</rptOwnerStreet1>
            <rptOwnerStreet2>3 HATNUFA ST., P.O. BOX 161</rptOwnerStreet2>
            <rptOwnerCity>YOKNEAM ILIT</rptOwnerCity>
            <rptOwnerState>L3</rptOwnerState>
            <rptOwnerZipCode>20692203</rptOwnerZipCode>
            <rptOwnerStateDescription>ISRAEL</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Ordinary Shares, par value NIS 0.01 per share</value>
            </securityTitle>
            <transactionDate>
                <value>2016-05-23</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>S</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness></transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>1200</value>
                    <footnoteId id="F1"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>9.00</value>
                    <footnoteId id="F2"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>1744752</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>By partnership</value>
                    <footnoteId id="F3"/>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Ordinary Shares, par value NIS 0.01 per share</value>
            </securityTitle>
            <transactionDate>
                <value>2016-05-24</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>S</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness></transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>200</value>
                    <footnoteId id="F4"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>8.95</value>
                    <footnoteId id="F5"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>1744552</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>By partnership</value>
                    <footnoteId id="F3"/>
                    <footnoteId id="F6"/>
                    <footnoteId id="F7"/>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Ordinary Shares, par value NIS 0.01 per share</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>6022</value>
                    <footnoteId id="F8"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>ESOP</value>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">The disposed of securities consist of 900 Ordinary Shares sold by SCP Vitalife Partners II, L.P. (&quot;SCP Vitalife&quot;) and 300 shares sold by SCP Vitalife Partners (Israel) II, L.P. (&quot;SCP Vitalife Israel&quot;).</footnote>
        <footnote id="F2">The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions each at a price of $9.00 per share. The reporting person undertakes to provide to ReWalk Robotics Ltd. (&quot;ReWalk&quot;), any security holder of ReWalk, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction at the price set forth in this footnote (1) to this Form 4.</footnote>
        <footnote id="F3">The Reporting Person is a director of SCP Vitalife II GP, Ltd. (&quot;SCP Vitalife GP&quot;), which is the sole general partner of SCP Vitalife II Associates, L.P. (&quot;SCP Vitalife Associates&quot;). SCP Vitalife Associates is the sole general partner of each of SCP Vitalife and SCP Vitalife Israel, the direct beneficial owner of the Ordinary Shares.  The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of the Ordinary Shares held by SCP Vitalife and SCP Vitalife Israel, except to the extent of his pecuniary interest therein.</footnote>
        <footnote id="F4">The disposed of securities consist of 150 Ordinary Shares sold by SCP Vitalife and 50 shares sold by SCP Vitalife Israel.</footnote>
        <footnote id="F5">The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.90 to $9.00, inclusive. The reporting person undertakes to provide to ReWalk, any security holder of ReWalk, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4.</footnote>
        <footnote id="F6">As of May 25, 2016, SCP Vitalife Associates, as the general partner of SCP Vitalife and SCP Vitalife Israel, may be deemed to beneficially own 1,602,026 Ordinary Shares, which consist of 1,200,921 and 401,105 Ordinary Shares held by SCP Vitalife and SCP Vitalife Israel, respectively.  SCP Vitalife GP is the general partner of SCP Vitalife Associates and, as such, shares voting and dispositive power over, and may be deemed to beneficially own, the Ordinary Shares held by the foregoing entities.  The Reporting Person shares voting and dispositive power over, and may be deemed to beneficially own 1,744,552 Ordinary Shares, which consist of the Ordinary Shares as set forth in footnote (6) to this Form 4.</footnote>
        <footnote id="F7">As of May 25, 2016, consists of 1,602,026 Ordinary Shares held by the foregoing entities due to the Reporting Person serving as a director of SCP Vitalife GP, as well as (i) 62,006 Ordinary Shares held by Vitalife Partners (Overseas) L.P., (ii) 20,506 Ordinary Shares held by Vitalife Partners (Israel) L.P., (iii) 20,733 Ordinary Shares held by Vitalife Partners (D.C.M) L.P. (&quot;Vitalife Partners DCM&quot;, and together with Vitalife Partners (Overseas) L.P. and Vitalife Partners (Israel) L.P., the &quot;Vitalife I Entities&quot;) and (iv) 39,281 Ordinary Shares currently held by the Office of the Chief Scientist of the State of Israel (&quot;OCS&quot;), that the Vitalife I Entities have the right to acquire from the OCS, due to the Reporting Person serving as a director of Vitalife Life Sciences Ltd., the general partner of Vitalife Partners Management L.P., which is the general partner of each of the Vitalife I Entities.</footnote>
        <footnote id="F8">Represents 6,022 ordinary shares issuable upon the vesting of restricted stock units (&quot;RSUs&quot;) granted on December 15, 2014 under the ReWalk 2014 Equity Incentive Plan. One-third, or 2,007 Ordinary Shares, of the RSUs vested on the first anniversary of the date of grant and the remaining RSUs vest in equal quarterly installments of 501 Ordinary Shares each starting one quarter after the first anniversary of the date of grant.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Kevin Hershberger, as attorney-in-fact</signatureName>
        <signatureDate>2016-05-25</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
